* Outset Medical Inc OM.OQ OM.O is expected to show a
rise in
quarterly revenue when it reports results
* The San Jose California-based company is expected to
report a
9.5% increase in revenue to $30.391 million from $27.76 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
* Refinitiv's mean analyst estimate for Outset Medical Inc
is for
a loss of 67 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $9, above its last closing price of $4.25.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.84 -0.76 -0.90 Missed -18
Mar. 31 2023 -0.78 -0.74 -0.90 Missed -21.3
Dec. 31 2022 -0.91 -0.86 -0.86 Met 0
Sep. 30 2022 -0.84 -0.81 -0.85 Missed -4.9
Jun. -0.68 -0.70 -0.92 Missed -31.8
30 2022
Mar. 31 2022 -0.71 -0.72 -0.78 Missed -8.3
Dec. 31 2021 -0.75 -0.77 -0.87 Missed -13.4
Sep. 30 2021 -0.77 -0.73 -0.65 Beat 11
This summary was machine generated November 4 at 03:05 GMT. All
figures in US dollars unless otherwise stated